APA (7th ed.) Citation

Buffi, N., Saita, A., Zuradelli, M., Casale, P., Hurle, R., Lughezzani, G., . . . Guazzoni, G. (2019). PT102 - Clinical impact of male BRCA2 germline pathogenic mutation: Preliminary results from a National Clinical Research Hospital. European Urology Supplements, 18(1), e1807. https://doi.org/10.1016/S1569-9056(19)31307-7

Chicago Style (17th ed.) Citation

Buffi, N., et al. "PT102 - Clinical Impact of Male BRCA2 Germline Pathogenic Mutation: Preliminary Results from a National Clinical Research Hospital." European Urology Supplements 18, no. 1 (2019): e1807. https://doi.org/10.1016/S1569-9056(19)31307-7.

MLA (9th ed.) Citation

Buffi, N., et al. "PT102 - Clinical Impact of Male BRCA2 Germline Pathogenic Mutation: Preliminary Results from a National Clinical Research Hospital." European Urology Supplements, vol. 18, no. 1, 2019, p. e1807, https://doi.org/10.1016/S1569-9056(19)31307-7.